Subscribe
mouse-1
Kerrick / iStockphoto.com
16 July 2020BiotechnologyDavid Fyfield

How patents for transgenic mice got caught in a sufficiency trap

In a blow for  Regeneron Pharmaceuticals, the  UK Supreme Court has reversed a  Court of Appeal decision by ruling that its patents relating to transgenic mice are invalid due to lack of “sufficiency”.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
Kymab victorious before UK Supreme Court in Regeneron appeal
24 June 2020   The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.
Big Pharma
Actavis v Eli Lilly: UK Supreme Court updates patent infringement test
12 July 2017   The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Biotechnology
Kymab victorious before UK Supreme Court in Regeneron appeal
24 June 2020   The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.
Big Pharma
Actavis v Eli Lilly: UK Supreme Court updates patent infringement test
12 July 2017   The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement.

More on this story

Biotechnology
Kymab victorious before UK Supreme Court in Regeneron appeal
24 June 2020   The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.
Big Pharma
Actavis v Eli Lilly: UK Supreme Court updates patent infringement test
12 July 2017   The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement.

More features

China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sanofi subsidiary fends off $450m trade secrets case
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
10x Genomics counsel: ‘Winning cases is a top priority’